Social Europe

politics, economy and employment & labour

  • Themes
    • Strategic autonomy
    • War in Ukraine
    • European digital sphere
    • Recovery and resilience
  • Publications
    • Books
    • Dossiers
    • Occasional Papers
    • Research Essays
    • Brexit Paper Series
  • Podcast
  • Videos
  • Newsletter

Hungary’s Covid-19 wars

Stephen Pogány 17th March 2021

For Viktor Orbán, the pandemic has offered an opportunity to undermine the European Union and curry favour with Hungary’s authoritarian allies.

Orbán,Hungary
Stephen Pogány

While Europe and most of the world is locked in a desperate battle with a virus which has already claimed the lives of well over two and a half million people, Hungary has been waging a war against multiple adversaries. The coronavirus is just one of several targets.

Hungary’s prime minister, Viktor Orbán, has insisted that ‘[h]uman lives and health stand above politics’ and that ‘[i]t’s irresponsible to turn vaccines into a political issue’. Yet it’s hard to resist the conclusion that his administration’s handling of the pandemic has been shaped by political considerations as well as informed medical opinion.

Orbán has an acrimonious relationship with the European Union, which he routinely castigates for its purportedly liberal asylum policies, support for multiculturalism, failure to uphold ‘Christian’ values and federalist tendencies. To the dismay of the Netherlands and others, Orbán, along with the government of Mateusz Morawiecki in Poland, fought efforts by the EU to introduce meaningful sanctions for member countries which violate the rule of law.

For their part, the European Parliament and several members of the European Commission have criticised Hungary for traducing the union’s core values, while the European Court of Justice has declared Orbán’s assaults on the Central European University and on Hungarian non-governmental organisations unlawful.


Our job is keeping you informed!


Subscribe to our free newsletter and stay up to date with the latest Social Europe content. We will never send you spam and you can unsubscribe anytime.

Sign up here

Doubt cast

As early as December 4th last year, Orbán condemned the EU for unacceptable delays in the rollout of vaccines by pharmaceutical companies with which the commission had negotiated contracts. With heavy sarcasm, he told Kossuth Radio: ‘The gentlemen over here [in Brussels] spend all their time in political debates about the rule of law.’ Although he was unable to offer any evidence, Orbán also cast doubt on the integrity of western pharmaceutical companies whom he accused of pursuing their own interests at the expense of ordinary people.

In what was widely seen as a further attempt to undermine the credibility and cohesion of the EU, Hungary became the first member state to order additional quantities of vaccine directly, rather than relying on supplies purchased centrally by the EU. With a population of fewer than ten million, Hungary bought five million doses of the Chinese Sinopharm vaccine and two million shots of Russia’s Sputnik V—on top of the 12 million doses it had already contracted to purchase through the EU.

Inoculation of Hungarians with the Russian and Chinese vaccines began in February—despite neither drug having been approved by the European Medicines Agency (EMA) and in the face of significant public resistance to Sinopharm, in particular. Pensioners and others, faced with a rapidly worsening pandemic, were left having to choose between accepting the only vaccine on offer or waiting indefinitely for an alternative, such as Pfizer or Moderna, which had been thoroughly tested. Hungary’s former chief medical officer, Ferenc Falus, described the government’s conduct as ‘abusive’.

Wayward behaviour

It would be naïve to imagine the purchase of Russian and Chinese vaccines was simply a pragmatic response to an unprecedented crisis. Under Orbán, Hungary has increasingly aligned itself with Russia and China—neither of which is troubled by his enthusiasm for ‘illiberal democracy’, mounting evidence of systematic corruption or his government’s assaults on media pluralism, human rights and the rule of law. By contrast, the EU and the centre-right European People’s Party—the largest bloc in the European Parliament—are exasperated by the wayward behaviour of Orbán and his party, Fidesz. To avoid the humiliation of formal exclusion, Fidesz MEPs recently left the EPP.

Orbán has long claimed that the EU is sclerotic and ‘ruled by the spirit of bureaucracy’—in contrast to China, which he believes is destined to become the pre-eminent global power. Acquiring the Chinese vaccine allowed him to curry favour with Beijing, while simultaneously undermining confidence in the EU’s ability to handle the pandemic.

For the Russian president, Vladimir Putin, too, sale of its vaccine to an EU member state offered prestige as well as profits. And any ensuing damage to the EU’s reputation and cohesion represented an additional gain for Orbán’s ally in Moscow.

Disturbing decision

The manufacturers of Sinopharm have still to request EMA approval, while the agency was unable to begin testing Sputnik V until early March because it had not been presented with sufficient data. Encouraging results of Phase III tests may now expedite its approval.

Orbán’s decision to purchase Chinese and Russian vaccines in advance of EMA endorsement—and before Phase III trials had been completed—was disturbing, although the government in Budapest seemed to regard bypassing the EMA as a matter of national pride: ‘Hungary is neither a half-colony nor a colony. We can make our own decisions,’ the state secretary, Tamás Menczer, declared in January.


We need your support


Social Europe is an independent publisher and we believe in freely available content. For this model to be sustainable, however, we depend on the solidarity of our readers. Become a Social Europe member for less than 5 Euro per month and help us produce more articles, podcasts and videos. Thank you very much for your support!

Become a Social Europe Member

Under a government decree adopted on January 28th—apparently intended to facilitate the introduction of the Chinese vaccine—medicines can be granted permission for emergency use in Hungary provided they have already been authorised in at least three countries, one of which is an EU member or candidate, and the medicines have been administered to at least one million people. Previously, new drugs could only be given temporary authorisation for emergency use if they had been examined by the National Institute of Pharmacy and Nutrition and were already in use in a European Economic Area member.

In effect, the decree replaces rigorous scientific review by an independent body of experts with a simple bureaucratic procedure which is ultimately subject to political oversight. ‘The Hungarian [scientific] authorities have been degraded to the status of a rubber stamp,’ Dr Tamás Svéd, secretary of the Hungarian Chamber of Physicians, complained.

Politically driven

The EU’s response to Covid-19 can hardly be described as an unqualified success. With the pandemic raging in Slovakia and Czechia, the governments in Bratislava and Prague have followed Hungary’s example, ordering vaccines from Russia and China respectively. But the timing of Orbán’s negotiations with Moscow and Beijing, for the supply of vaccines, suggests that the decision was politically driven and that there may have been other motives as well.

Orbán’s claim that the purchase of the vaccines was necessary because of failures by the EU and western pharmaceutical companies is difficult to sustain in view of the fact that Hungary has opted to take up little more than half of the US-developed Moderna shots available to it under contracts negotiated by the EU, offering mutually contradictory explanations for its decision.

At the same time, Hungary has not made effective use of the shots already supplied to it, performing worse than any other EU member in terms of the number of doses it has administered as a proportion of the vaccines it has received. In recent days, disturbing reports have emerged suggesting that Hungary purchased the Sinopharm vaccine at an inflated price and that a potentially significant part of the proceeds went to Danubia Pharma, a local wholesale drug company, whose true owners remain unknown.

Orbán’s handling of the pandemic may come at a heavy cost to the health and wellbeing of Hungarians.

Stephen Pogány
Stephen Pogány

Stephen Pogány is emeritus professor in the School of Law, University of Warwick. His latest book is Modern Times: The Biography of a Hungarian-Jewish Family (2021).

You are here: Home / Politics / Hungary’s Covid-19 wars

Most Popular Posts

Visentini,ITUC,Qatar,Fight Impunity,50,000 Visentini, ‘Fight Impunity’, the ITUC and QatarFrank Hoffer
Russian soldiers' mothers,war,Ukraine The Ukraine war and Russian soldiers’ mothersJennifer Mathers and Natasha Danilova
IGU,documents,International Gas Union,lobby,lobbying,sustainable finance taxonomy,green gas,EU,COP ‘Gaslighting’ Europe on fossil fuelsFaye Holder
Schengen,Fortress Europe,Romania,Bulgaria Romania and Bulgaria stuck in EU’s second tierMagdalena Ulceluse
income inequality,inequality,Gini,1 per cent,elephant chart,elephant Global income inequality: time to revise the elephantBranko Milanovic

Most Recent Posts

Pakistan,flooding,floods Flooded Pakistan, symbol of climate injusticeZareen Zahid Qureshi
reality check,EU foreign policy,Russia Russia’s invasion of Ukraine: a reality check for the EUHeidi Mauer, Richard Whitman and Nicholas Wright
permanent EU investment fund,Recovery and Resilience Facility,public investment,RRF Towards a permanent EU investment fundPhilipp Heimberger and Andreas Lichtenberger
sustainability,SDGs,Finland Embedding sustainability in a government programmeJohanna Juselius
social dialogue,social partners Social dialogue must be at the heart of Europe’s futureClaes-Mikael Ståhl

Other Social Europe Publications

front cover scaled Towards a social-democratic century?
Cover e1655225066994 National recovery and resilience plans
Untitled design The transatlantic relationship
Women Corona e1631700896969 500 Women and the coronavirus crisis
sere12 1 RE No. 12: Why No Economic Democracy in Sweden?

Foundation for European Progressive Studies Advertisement

The winter issue of the Progressive Post magazine from FEPS is out!

The sequence of recent catastrophes has thrust new words into our vocabulary—'polycrisis', for example, even 'permacrisis'. These challenges have multiple origins, reinforce each other and cannot be tackled individually. But could they also be opportunities for the EU?

This issue offers compelling analyses on the European health union, multilateralism and international co-operation, the state of the union, political alternatives to the narrative imposed by the right and much more!


DOWNLOAD HERE

Hans Böckler Stiftung Advertisement

The macroeconomic effects of re-applying the EU fiscal rules

Against the background of the European Commission's reform plans for the Stability and Growth Pact (SGP), this policy brief uses the macroeconometric multi-country model NiGEM to simulate the macroeconomic implications of the most relevant reform options from 2024 onwards. Next to a return to the existing and unreformed rules, the most prominent options include an expenditure rule linked to a debt anchor.

Our results for the euro area and its four biggest economies—France, Italy, Germany and Spain—indicate that returning to the rules of the SGP would lead to severe cuts in public spending, particularly if the SGP rules were interpreted as in the past. A more flexible interpretation would only somewhat ease the fiscal-adjustment burden. An expenditure rule along the lines of the European Fiscal Board would, however, not necessarily alleviate that burden in and of itself.

Our simulations show great care must be taken to specify the expenditure rule, such that fiscal consolidation is achieved in a growth-friendly way. Raising the debt ceiling to 90 per cent of gross domestic product and applying less demanding fiscal adjustments, as proposed by the IMK, would go a long way.


DOWNLOAD HERE

ILO advertisement

Global Wage Report 2022-23: The impact of inflation and COVID-19 on wages and purchasing power

The International Labour Organization's Global Wage Report is a key reference on wages and wage inequality for the academic community and policy-makers around the world.

This eighth edition of the report, The Impact of inflation and COVID-19 on wages and purchasing power, examines the evolution of real wages, giving a unique picture of wage trends globally and by region. The report includes evidence on how wages have evolved through the COVID-19 crisis as well as how the current inflationary context is biting into real wage growth in most regions of the world. The report shows that for the first time in the 21st century real wage growth has fallen to negative values while, at the same time, the gap between real productivity growth and real wage growth continues to widen.

The report analysis the evolution of the real total wage bill from 2019 to 2022 to show how its different components—employment, nominal wages and inflation—have changed during the COVID-19 crisis and, more recently, during the cost-of-living crisis. The decomposition of the total wage bill, and its evolution, is shown for all wage employees and distinguishes between women and men. The report also looks at changes in wage inequality and the gender pay gap to reveal how COVID-19 may have contributed to increasing income inequality in different regions of the world. Together, the empirical evidence in the report becomes the backbone of a policy discussion that could play a key role in a human-centred recovery from the different ongoing crises.


DOWNLOAD HERE

ETUI advertisement

The EU recovery strategy: a blueprint for a more Social Europe or a house of cards?

This new ETUI paper explores the European Union recovery strategy, with a focus on its potentially transformative aspects vis-à-vis European integration and its implications for the social dimension of the EU’s socio-economic governance. In particular, it reflects on whether the agreed measures provide sufficient safeguards against the spectre of austerity and whether these constitute steps away from treating social and labour policies as mere ‘variables’ of economic growth.


DOWNLOAD HERE

Eurofound advertisement

Eurofound webinar: Making telework work for everyone

Since 2020 more European workers and managers have enjoyed greater flexibility and autonomy in work and are reporting their preference for hybrid working. Also driven by technological developments and structural changes in employment, organisations are now integrating telework more permanently into their workplace.

To reflect on these shifts, on 6 December Eurofound researchers Oscar Vargas and John Hurley explored the challenges and opportunities of the surge in telework, as well as the overall growth of telework and teleworkable jobs in the EU and what this means for workers, managers, companies and policymakers.


WATCH THE WEBINAR HERE

About Social Europe

Our Mission

Article Submission

Membership

Advertisements

Legal Disclosure

Privacy Policy

Copyright

Social Europe ISSN 2628-7641

Social Europe Archives

Search Social Europe

Themes Archive

Politics Archive

Economy Archive

Society Archive

Ecology Archive

Follow us

RSS Feed

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on YouTube